Teleflex (NYSE:TFX) Shares Gap Up – Still a Buy?

Teleflex Incorporated (NYSE:TFX)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $124.75, but opened at $136.00. Teleflex shares last traded at $136.7230, with a volume of 619,995 shares changing hands.

Wall Street Analysts Forecast Growth

TFX has been the subject of several analyst reports. Royal Bank Of Canada reissued a “sector perform” rating on shares of Teleflex in a research note on Tuesday, April 14th. Needham & Company LLC raised their price objective on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a research note on Monday, April 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Finally, Wall Street Zen downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $138.50.

Teleflex Trading Up 9.2%

The company has a market capitalization of $6.03 billion, a PE ratio of -6.61, a price-to-earnings-growth ratio of 0.95 and a beta of 0.84. The company’s fifty day moving average is $114.92 and its 200-day moving average is $116.23. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.54 and a quick ratio of 2.01.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The business had revenue of $569.00 million for the quarter, compared to analysts’ expectations of $912.57 million. During the same period in the previous year, the business earned $3.89 earnings per share. The business’s quarterly revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts anticipate that Teleflex Incorporated will post 6.77 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, March 6th. Teleflex’s payout ratio is currently -6.62%.

Institutional Investors Weigh In On Teleflex

A number of large investors have recently made changes to their positions in TFX. Empowered Funds LLC grew its holdings in shares of Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after buying an additional 230 shares during the last quarter. Jane Street Group LLC lifted its position in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after purchasing an additional 1,895 shares during the period. American Century Companies Inc. lifted its position in Teleflex by 32.7% during the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after purchasing an additional 3,360 shares during the period. Invesco Ltd. lifted its position in Teleflex by 1.2% during the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after purchasing an additional 1,659 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its position in Teleflex by 108.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after purchasing an additional 521 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.